Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT UBC Medical Indonesia TbkISX:LABS +2.55% Return-on-Tangible-Asset is 0.00% as of . 20. The stock has 2 warning signs investors should review. Among 855 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 116958.95% on this metric.
The historical rank and industry rank for PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset or its related term are showing as below:
ISX:LABS's Return-on-Tangible-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.74 * Ranked among companies with meaningful Return-on-Tangible-Asset only.
PT UBC Medical Indonesia Tbk (ISX:LABS) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
PT UBC Medical Indonesia Tbk Return-on-Tangible-Asset Related Terms
PT UBC Medical Indonesia Tbk Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT UBC Medical Indonesia Tbk Return-on-Tangible-Asset Chart
PT UBC Medical Indonesia Tbk Annual Data
Trend
Return-on-Tangible-Asset
PT UBC Medical Indonesia Tbk Semi-Annual Data
Return-on-Tangible-Asset
ISX:LABS vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT UBC Medical Indonesia Tbk Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (. 20) net income data.
What does a Return-on-Tangible-Asset of 0.00% mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Return-on-Tangible-Asset of 0.00% as of . 20. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 855 companies in the Medical Devices & Instruments industry.
Is PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset too high?
PT UBC Medical Indonesia Tbk's current Return-on-Tangible-Asset is 0.00%. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does PT UBC Medical Indonesia Tbk's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 855 companies for Return-on-Tangible-Asset. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Return-on-Tangible-Asset of 0.00%. The current Return-on-Tangible-Asset is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LABS has been successfully added to your 
